Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-operative Chemotherapy

NCT00134030 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00134030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00134030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-operative Chemotherapy
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
November 14, 2005
Completion date
September 30, 2022
Enrollment
1,334 (actual)
Sites
218

Conditions

As the registry lists them; a condition with its own page is linked.

localized osteosarcoma, metastatic osteosarcoma